{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:26:46Z","timestamp":1780079206047,"version":"3.54.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jdcr.2021.10.018","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T17:02:25Z","timestamp":1635181345000},"page":"71-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Urticaria multiforme-like eruption due to a novel agent elexacaftor\/tezacaftor\/ivacaftor in a pediatric patient with cystic fibrosis"],"prefix":"10.1016","volume":"18","author":[{"given":"Rebecca H.","family":"Goldberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie H.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra C.","family":"Hristov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdcr.2021.10.018_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ad.2015.01.003","article-title":"Urticaria multiforme: a report of 5 cases and a review of the literature","volume":"107","author":"Sempau","year":"2016","journal-title":"Actas Dermosifiliogr"},{"issue":"3","key":"10.1016\/j.jdcr.2021.10.018_bib2","first-page":"34","article-title":"Urticaria multiforme","volume":"6","author":"Emer","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2021.10.018_bib3","doi-asserted-by":"crossref","first-page":"e1177","DOI":"10.1542\/peds.2006-1553","article-title":"\u201cUrticaria multiforme\u201d: a case\u00a0series and review of acute annular urticarial hypersensitivity syndromes in children","volume":"119","author":"Shah","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.jdcr.2021.10.018_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1164\/rccm.202008-3176LE","article-title":"Safety and efficacy of elexacaftor\/tezacaftor\/ivacaftor for 24 weeks or longer in people with cystic fibrosis and one or more F508del alleles: interim results of an open-label phase 3 clinical trial","volume":"203","author":"Griese","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.jdcr.2021.10.018_bib6","doi-asserted-by":"crossref","first-page":"e04116","DOI":"10.1002\/ccr3.4116","article-title":"Novel reaction to new cystic fibrosis medication Trikafta","volume":"9","author":"Stashower","year":"2021","journal-title":"Clin Case Rep"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512621007591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512621007591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:23:08Z","timestamp":1762474988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512621007591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":5,"alternative-id":["S2352512621007591"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.10.018","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urticaria multiforme-like eruption due to a novel agent elexacaftor\/tezacaftor\/ivacaftor in a pediatric patient with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}